COMPANY INFO
K Health, officially known as K Health Inc., was founded in 2016 by Allon Bloch, Ran Shaul, Israel Roth, and Adam Singolda. It is a privately held company in the healthcare industry with around 349-398 employees, headquartered in New York, NY. K Health uses clinical artificial intelligence to provide virtual primary care through health systems, insurers, and its mobile app, aiming to give everyone access to high-quality, affordable healthcare. The company's platform leverages AI to deliver personalized care and medical insights remotely, available 24/7 to millions of users. Their website is https://khealth.com.
This page is built with Exa, a web search API for AI agents. It is updated every 24 hours.
K Health, officially known as K Health Inc., was founded in 2016 by Allon Bloch, Ran Shaul, Israel Roth, and Adam Singolda. Operating in the healthcare industry and headquartered in New York, NY, K Health employs approximately 349-398 people. The company leverages clinical artificial intelligence to deliver virtual primary care through partnerships with health systems, insurers, and directly via its mobile app. K Health’s platform provides users with 24/7 access to high-quality, affordable, and personalized healthcare, backed by AI-driven medical insights.
K Health funding has been pivotal to the company's rapid growth and innovation. Since its inception, K Health has completed 13 funding rounds, raising a total of $439 million. The most recent Series F round in July 2024 brought in $88.4 million, led by Claure Group and aimed at expanding K Health’s clinical AI capabilities and reach within major health systems. Over the years, K Health investors have included renowned venture capital firms and strategic partners, supporting the company’s AI development, market expansion, and scaling of telehealth services. This steady funding cadence reflects a robust funding strategy focused on sustained product evolution and market leadership in digital health.
The Series F round was led by Claure Group and will be used to expand K Health’s clinical artificial intelligence in personalized primary care in partnership with leading health systems.
An additional Series E investment to support ongoing growth and further enhancement of K Health’s AI platform.
This Series E round, backed by Sinai, Valor Equity Partners, Mangrove Capital Partners, and PICO Partners, focused on fueling growth and building out K Health’s AI-powered medical services.
Led by Valor Equity Partners and others, this Series E round supported market expansion and scaling of the AI primary care platform. The company achieved a valuation of $1.5B.
Series D funding advanced platform development and expanded market reach, with investment from Valor Equity Partners, Marcy Venture Partners, and others.
Led by Mangrove Capital Partners and joined by several top venture capital firms, this Series C was focused on product development and scaling business operations.
This round supported continued growth and market penetration as K Health expanded its user base and offerings.
Raised for market expansion and product enhancements, this Series B involved 14W, Comcast Ventures, Mangrove Capital Partners, and more.
Targeted towards product development and initial market entry, this round included Mangrove Capital Partners, Lerer Hippeau, Primary Venture Partner, and others.
Raised to support early product development and team growth as K Health established its telehealth offerings.
Early seed capital from Mangrove Capital Partners, Bessemer Venture Partners, and others to fund initial launch and product development.
This round enabled continued early-stage development and supported initial operations.
Seed funding from Max Ventures provided foundational capital for company formation and first product iterations.
Claure Group led K Health’s latest Series F round, playing a crucial role in scaling the company’s AI-driven healthcare platform and expanding partnerships with major health systems.
A repeat investor across multiple rounds, Mangrove Capital Partners has supported K Health since its earliest days, backing AI development and international expansion.
Valor Equity Partners has been a lead investor in key rounds, including the $132M Series E and Series D, contributing strategic guidance and growth capital.
As an investor in Series E, Sinai has enabled K Health’s growth and further development of its AI-powered medical services.
Participated in Series D, supporting K Health’s advancements in digital health platform technology and market reach.
With participation across several funding rounds, PICO Partners has been instrumental in helping shape K Health’s funding strategy and innovation roadmap.
An investor in the $132M Series E, GGV Capital bolstered K Health’s market expansion and AI initiatives.
Involved in multiple rounds, 14W has helped finance product enhancements and user base growth.
A strategic investor supporting K Health’s expansion and technology development.
Lerer Hippeau has backed K Health from seed through growth rounds, supporting early innovation and US expansion.
A significant supporter from the seed stage, Bessemer Venture Partners has provided essential early-stage capital and business expertise.
BoxGroup has invested in several rounds, providing consistent capital and support for K Health’s growth.
Contributed to Series D and E financing, bolstering K Health’s product and market development.
Provided initial seed funding, helping K Health launch and establish its core product.
A long-term investor, Primary Venture Partner has played a valuable role in K Health funding rounds and strategic development.
Participated in early seed funding to help launch the company's platform.
Key backers in larger rounds, supporting K Health’s expansion and AI-driven healthcare mission.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching K Health funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.
This page is built with Exa, a web search API for AI agents. It is updated every 24 hours.
Exa searches the web, extracts relevant source content, and returns structured outputs with citations.
const run = await exa.agent.runs.create({
query: "Research K Health's funding rounds, key investors, total raised, and latest funding date. Return structured JSON with field-level citations.",
effort: "low",
outputSchema: {
// company, fundingRounds, keyInvestors, totalRaised
/* ... */
}
});
const result = await exa.agent.runs.pollUntilFinished(run.id);{
"status": "completed",
"output": {
"structured": {
"company": "K Health",
"fundingRounds": [
"..."
],
"keyInvestors": [
"..."
],
"totalRaised": "K Health has raised a total of $439 million over 13 funding rounds. The latest funding round was a Series F round on July 1, 2024, raising $88.4 million led by Claure Group. Key investors include Claure Group, Mangrove Capital Partners, Valor Equity Partners, Atreides Management, Sinai, PICO Partners, GGV Capital, 14W, Comcast Ventures, Lerer Hippeau, Bessemer Venture Partners, Max Ventures, and others. Detailed breakdown of funding rounds: 1) Jul 1, 2024: $88.4M Series F led by Claure Group for AI-powered medical services expansion and growth. 2) Dec 22, 2023: $8M Series E. 3) Jul 17, 2023: $59M Series E with investors including Sinai and Valor Equity Partners. 4) Jan 19, 2021: $132M Series E led by Valor Equity Partners for market expansion and product development. 5) Nov 18, 2020: $42M Series D led by Valor Equity Partners and others. 6) Mar 2, 2020: $48M Series C with Mangrove Capital Partners and others. 7) Jul 23, 2019: $12M Series B. 8) Dec 17, 2018: $25M Series B with 14W and Comcast Ventures. 9) Jul 17, 2018: $12.5M Series A led by Mangrove Capital Partners. 10) Jan 30, 2018: $5.12M Series A. 11) Jun 13, 2017: $3.2M Seed. 12) Nov 17, 2016: $3.3M Seed led by Mangrove Capital Partners. 13) 2016: Undisclosed Seed by Max Ventures. This funding has been used for AI development, product development, market expansion, and scaling healthcare services."
},
"grounding": [
{
"field": "fundingRounds[0].amount",
"citations": [
{
"url": "..."
}
]
}
]
}
}